The Cost-Saving Benefits of Direct-to-Consumer Telehealth for Employees
June 25th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the June 2023 issue of The American Journal of Managed Care® about how employers and their employees are utilizing direct-to-consumer telehealth to reduce the cost of care.
Read More
Signs of Depression Linked to mAb Therapy Nonresponse in Patients With Severe Asthma
June 23rd 2023A recent study found that depressive symptoms improved among patients with severe asthma who responded to monoclonal antibody (mAb) therapy, but baseline depression symptoms were associated with lower therapy response rates.
Read More
Dr Andy Blauvelt: Drug Approval, Accessibility Challenges in Treating Patients With AD
June 22nd 2023Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses challenges many physicians face in getting approved for the most effective drugs to treat patients with atopic dermatitis (AD).
Read More
Video-Based Education Improves Inhaler Use Among Adults With COPD
June 16th 2023A video-based teach-to-goal (TTG) intervention was able to improve inhaler technique over time among patients with chronic obstructive pulmonary disease (COPD) and asthma, according to a randomized controlled trial.
Read More
Dr Susan Escudier on How Oncologists and PCPs Can Work Together to Improve Value-Based Care
June 14th 2023Susan Escudier, MD, FACP, vice president of value-based and quality programs for Texas Oncology, discusses how collaboration between oncologists and primary care physicians (PCPs) can improve patient satisfaction and outcomes.
Read More
Using race-neutral rather than race and ethnicity-specific reference equations to interpret pulmonary function tests (PFTs) increased the number of Black individuals considered to have respiratory impairments, suggesting that race and ethnicity-specific equations may reinforce health disparities.
Read More
Dr Robert Sidbury: Best Practices for Managing Atopic Dermatitis in Infants
June 6th 2023Robert Sidbury, MD, MPH, professor of pediatrics at Seattle Children's Hospital, discusses best practices that physicians and parents of infants with atopic dermatitis (AD) can do to help manage flare- ups, as well as barriers to care, which he presented at the Revolutionizing Atopic Dermatitis conference.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Read More
Dr Melinda Gooderham Discusses Studies on Emerging Therapies for Atopic Dermatitis
May 18th 2023Melinda Gooderham, MD, MSc, FRCPC, Peterborough Regional Health Centre in Ontario, Canada, discusses recent trials and studies that have been conducted on emerging therapies for patients with atopic dermatitis.
Read More
Monoclonal Antibodies Targeting IL-5/IL-5R May Benefit Certain Patients With COPD
May 12th 2023Chronic obstructive pulmonary disease (COPD) exacerbations and oral corticosteroid use dropped in patients treated with monoclonal antibodies targeting interleukin (IL)-5 and its receptor (IL-5R), a study found.
Read More
Dr Fran Gregory Discusses the Impact of the New Wave of Biosimilars on Rebate Practices
May 8th 2023Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses the role the new wave of biosimilars will have on rebate practices for both pharmacy benefit managers (PBMs) and payers.
Read More
Dr Neal Dave Discusses NCODA's Pharmacy Accreditation Programs
May 4th 2023Neal Dave, PharmD, executive director of pharmacy operations at Texas Oncology, discusses updates to the National Community Oncology Dispensing Association (NCODA) Center of Excellence pharmacy accreditation program.
Read More
NHIA's Connie Sullivan Discusses the Benefits and Patient Satisfaction of Home Infusion
May 3rd 2023Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with home administration.
Read More
Dr Andy Blauvelt on Selecting the Right Patient for Systemic Therapy or Biologics to Treat AD
May 2nd 2023Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses the use of systemic therapies vs biologics and why adherence is so important when treating patients with atopic dermatitis (AD).
Read More